Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser Citadel Group | (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A | (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree BRERA HOLDINGS PLC | (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) N/A | (e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure 14 July 2026 | (f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" YES FORWARD INDUSTRIES INC |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security (Note 3) ISIN IE0009876H30 $0.50 class B ordinary shares | Interests Short positions | Number % Number % | (1) Relevant securities owned and/or controlled 255,315 2.31 401 0.00 | (2) Cash-settled derivatives 0 0.00 0 0.00 | (3) Stock-settled derivatives (including options) and agreements to purchase/ sell 0 0.00 0 0.00 | Total 255,315 2.31 401 0.00 |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit (Note 5) | Common Buy Transaction 300 5.5200 USD | Common Buy Transaction 343 5.5571 USD | Common Buy Transaction 72 5.5600 USD | Common Buy Transaction 100 5.5700 USD | Common Buy Transaction 350 5.5843 USD | Common Buy Transaction 772 5.5855 USD | Common Buy Transaction 1 5.5900 USD | Common Buy Transaction 1,265 5.6157 USD | Common Buy Transaction 4 5.6400 USD | Common Buy Transaction 68 5.6406 USD | Common Buy Transaction 304 5.6600 USD | Common Buy Transaction 430 5.6721 USD | Common Buy Transaction 25 5.6796 USD | Common Buy Transaction 16 5.6800 USD | Common Buy Transaction 460 5.6916 USD | Common Buy Transaction 3,885 5.6944 USD | Common Buy Transaction 500 5.7098 USD | Common Buy Transaction 100 5.7100 USD | Common Buy Transaction 11,010 5.7191 USD | Common Buy Transaction 1 5.7200 USD | Common Buy Transaction 10 5.7270 USD | Common Buy Transaction 100 5.7302 USD | Common Buy Transaction 17 5.7359 USD | Common Buy Transaction 392 5.7432 USD | Common Buy Transaction 2 5.7500 USD | Common Buy Transaction 1,750 5.7553 USD | Common Buy Transaction 120 5.7600 USD | Common Buy Transaction 276 5.7652 USD | Common Buy Transaction 20 5.7710 USD | Common Buy Transaction 2 5.7750 USD | Common Buy Transaction 15 5.7800 USD | Common Buy Transaction 221 5.7857 USD | Common Buy Transaction 86 5.7926 USD | Common Buy Transaction 100 5.8000 USD | Common Buy Transaction 2 5.8550 USD | Common Buy Transaction 200 5.8700 USD | Common Buy Transaction 400 5.8800 USD | Common Buy Transaction 753 5.9000 USD | Common Buy Transaction 121 5.9100 USD | Common Buy Transaction 1,080 5.9539 USD | Common Buy Transaction 56 5.9643 USD | Common Buy Transaction 50 6.0410 USD | Common Buy Transaction 10 6.1100 USD | Common Buy Transaction 516 6.1200 USD | Common Buy Transaction 1 6.1900 USD | Common Buy Transaction 2,438 6.1901 USD | Common Buy Transaction 562 6.1901 USD | Common Buy Transaction 31 6.2100 USD | Common Buy Transaction 56 6.2346 USD | Common Buy Transaction 105 6.2376 USD | Common Buy Transaction 9 6.2600 USD | Common Buy Transaction 7 6.2900 USD | Common Buy Transaction 82 6.3000 USD | Common Buy Transaction 891 6.3045 USD | Common Buy Transaction 100 6.3400 USD | Common Buy Transaction 137 6.3500 USD | Common Buy Transaction 500 6.3700 USD | Common Buy Transaction 163 6.3708 USD | Common Buy Transaction 103 6.3800 USD | Common Buy Transaction 1,000 6.4000 USD | Common Buy Transaction 101 6.4100 USD | Common Buy Transaction 325 6.4400 USD | Common Buy Transaction 42 6.4500 USD | Common Buy Transaction 35 6.4569 USD | Common Buy Transaction 69 6.6300 USD | Common Sell Transaction 10 5.5100 USD | Common Sell Transaction 230 5.5270 USD | Common Sell Transaction 313 5.5600 USD | Common Sell Transaction 9,000 5.5900 USD | Common Sell Transaction 100 5.5935 USD | Common Sell Transaction 117 5.6215 USD | Common Sell Transaction 30 5.6400 USD | Common Sell Transaction 230 5.6600 USD | Common Sell Transaction 4 5.6800 USD | Common Sell Transaction 2 5.7000 USD | Common Sell Transaction 200 5.7050 USD | Common Sell Transaction 100 5.7100 USD | Common Sell Transaction 199 5.7145 USD | Common Sell Transaction 24 5.7192 USD | Common Sell Transaction 3 5.7200 USD | Common Sell Transaction 10 5.7300 USD | Common Sell Transaction 8,741 5.7449 USD | Common Sell Transaction 6 5.7617 USD | Common Sell Transaction 712 5.7623 USD | Common Sell Transaction 1 5.7700 USD | Common Sell Transaction 30 5.7933 USD | Common Sell Transaction 507 5.8238 USD | Common Sell Transaction 3,177 5.8340 USD | Common Sell Transaction 454 5.8444 USD | Common Sell Transaction 500 5.8640 USD | Common Sell Transaction 291 5.8780 USD | Common Sell Transaction 4,534 5.8901 USD | Common Sell Transaction 100 5.9000 USD | Common Sell Transaction 165 5.9061 USD | Common Sell Transaction 15 5.9100 USD | Common Sell Transaction 2 5.9500 USD | Common Sell Transaction 1,500 6.0067 USD | Common Sell Transaction 1 6.0300 USD | Common Sell Transaction 161 6.1039 USD | Common Sell Transaction 41 6.1051 USD | Common Sell Transaction 5,630 6.1320 USD | Common Sell Transaction 502 6.1400 USD | Common Sell Transaction 100 6.1950 USD | Common Sell Transaction 308 6.2109 USD | Common Sell Transaction 50 6.2200 USD | Common Sell Transaction 16 6.2731 USD | Common Sell Transaction 82 6.2999 USD | Common Sell Transaction 2,100 6.3000 USD | Common Sell Transaction 133 6.3300 USD | Common Sell Transaction 2 6.3500 USD | Common Sell Transaction 536 6.3513 USD | Common Sell Transaction 325 6.4400 USD | Common Sell Transaction 505 6.4920 USD | Common Sell Transaction 38 6.6400 USD | Common Sell Transaction 480 6.6410 USD | Common Sell Transaction 101 6.6415 USD |
Ap29
(b) Cash-settled derivative transactions
Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of
relevant
security
Product
description e.g. call
option
Writing, purchasing, selling, varying
etc.
Number
of
securities
to which
option
relates
(Note 6)
Exercise
price per
unit
Type
e.g.
American,
European
etc.
Expiry
date
Option
money
paid/
received per unit
(ii) Exercise
Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
Details
Price per unit (if
applicable)
(Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
(c) Attachments
Is a Supplemental Form 8 attached?
NO
Date of disclosure 15 July 2026 | Contact name Paula Santos | Telephone number 020 7645 9700 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPAKPBKNBKDFOD